NCT02243995

Brief Summary

Exercise intolerance, muscle weakness and fatigue complaints are frequent and persistent problems in sarcoidosis. These physical impairments are disabling and affect quality of life in a negative way. The aetiology of these physical impairments is multifactorial. Physical inactivity can cause deconditioning, resulting in more perceived fatigue and muscle weakness. These symptoms may be partially reversible following a structured physical training program. However, scientific studies about physical training in sarcoidosis are lacking. Therefore, the aim of the present study is to examine the changes in fatigue complaints, physical functioning and quality of life (QOL) in patients with sarcoidosis following a 13-week physical training program. After obtaining written informed consent, sarcoidosis patients will start a 13-week physical training program for three times a week. This training program includes peripheral muscle training for both the upper and lower extremities (starting at 40% of the multiple-repetition maximum) and endurance training consisting of walking on a treadmill (starting at 60% of the speed of the 6-minute walk test) or cycling on a ergometer (starting at 50% of the Wmax). Participants will be assessed at baseline (week 0), at the end (13 weeks) and 3 months after ending the training. During these assessments, patients perform muscle strength (m. quadriceps and m. biceps) and exercise tests (six-minute walk test and submaximal endurance cycling test). They also complete several questionnaires: Fatigue Assessment Scale (FAS), World Health Organization Quality of Life assessment instrument-BREF (WHOQOL-BREF), Small Fiber Neuropathy Screening List (SFNSL), Medical Research Council (MRC), Visual Analogue Scale (VAS) and Hospital Anxiety and Depression Scale (HADS)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

September 18, 2014

Completed
Last Updated

January 9, 2018

Status Verified

September 1, 2014

Enrollment Period

1.2 years

First QC Date

February 18, 2013

Last Update Submit

January 5, 2018

Conditions

Keywords

Training programResistance trainingEndurance trainingMuscle strengthExercise capacityFatigueQuality of life

Outcome Measures

Primary Outcomes (1)

  • Cange in Fatigue Assessment Scale (FAS)at 3 months after end of the training

    The 10-item FAS is a fatigue scale. Each item has a 5-point rating scale and FAS scores range from 10-50. FAS scores \<22 indicate nonfatigue persons and scores of 22-34 indicate fatigued persons.

    baseline (week 0), at the end (week 13) and 3 months after ending the training

Study Arms (1)

Physical training

EXPERIMENTAL
Other: Physical trainingBehavioral: Physical training

Interventions

Physical training

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are diagnosed with sarcoidosis according to the WASOG guideline.
  • Fatigued patients ((FAS-score ≥ 22 points) and/or a reduced six-minute walking distance (predicted six-minute walking distance -50 m).
  • Patients who signed the consent form and are able to participate in a training program.
  • Minimum age 18 years and maximum age 70 years.
  • Clinically stable: no exacerbation of complaints, or changes in initiated therapeutic management during the preceding 3 months.

You may not qualify if:

  • Patients with a cognitive failure, making them unable to understand questionnaires and instructions.
  • Patients with a oncological, cardiac, neurological or orthopedic history making them unable to participate in a training program.
  • Patients who are unfamiliar with the Dutch language, disabling them to understand questionnaires and instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fysiomedica

Geleen, Limburg, 6161 ST, Netherlands

Location

Related Publications (3)

  • Marcellis RG, Lenssen AF, de Vries GJ, Baughman RP, van der Grinten CP, Verschakelen JA, De Vries J, Drent M. Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Lung. 2013 Feb;191(1):43-52. doi: 10.1007/s00408-012-9432-6. Epub 2012 Nov 9.

    PMID: 23138855BACKGROUND
  • Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J. 2011 Sep;38(3):628-34. doi: 10.1183/09031936.00117710. Epub 2011 Mar 24.

    PMID: 21436356BACKGROUND
  • Marcellis R, Van der Veeke M, Mesters I, Drent M, De Bie R, De Vries G, Lenssen A. Does physical training reduce fatigue in sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jun 22;32(1):53-62.

Related Links

MeSH Terms

Conditions

SarcoidosisFatigue

Interventions

Physical Conditioning, Human

Condition Hierarchy (Ancestors)

Lymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesHypersensitivity, DelayedHypersensitivityImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Antoine F. Lenssen, PhD

    Maastricht University Medical Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2013

First Posted

September 18, 2014

Study Start

January 1, 2013

Primary Completion

April 1, 2014

Study Completion

May 1, 2014

Last Updated

January 9, 2018

Record last verified: 2014-09

Locations